(Total Views: 115)
Posted On: 06/05/2023 11:30:47 AM
Post# of 27154

$CGEN News Article - Compugen's COM701 (anti-PVRIG) Demonstrates Preliminary Durable Anti-Tumor Activity in Triple Immunotherapy Combination in Patients with Recurrent Metastatic MSS Endometrial Cancer https://marketwirenews.com/news-releases/comp...75317.html


My Twitter: WhyteStocks